Gemmus develops innovative pharmaceutical products for the treatment of influenza and other viral infectious diseases.
Industries BiotechnologyHealth CarePharmaceuticalHeadquarters Regions San Francisco Bay Area, West Coast, Western US Founded Date 2007 Founders Daryl Faulds Operating Status Active Last Funding Type Series B
Company Type For Profit
Contact Email incoming@gemmuspharma.com Phone Number 4159781908
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and
Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.